Aspen Pharmacare Holdings Ltd (APN) – Strategy, SWOT and Corporate Finance Report

Aspen Pharmacare Holdings Ltd (APN) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Aspen Pharmacare Holdings Ltd (Aspen) is a provider of specialty and generic pharmaceuticals for the treatment of a range of acute and chronic conditions. The company focuses on thrombosis, anaesthetics and high potency and cytotoxic therapeutic categories. Its manufacturing capabilities cover a range of product types including oral solid dose, semi-solids, liquids, sterile, biological, personal care products and active pharmaceutical ingredients (APIs). The company has a presence in Sub-Saharan Africa, South East Asia, Latin America, Eastern Europe, Western Europe and the Commonwealth of Independent States. Aspen is headquartered in Durban, South Africa.

Scope

• Detailed information on Aspen Pharmacare Holdings Ltd required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Aspen Pharmacare Holdings Ltd in the form of a SWOT analysis

• An in-depth view of the business model of Aspen Pharmacare Holdings Ltd including a breakdown and examination of key business segments

• News about Aspen Pharmacare Holdings Ltd, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Aspen Pharmacare Holdings Ltd and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Aspen Pharmacare Holdings Ltd as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Aspen Pharmacare Holdings Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Novartis AG

Pfizer Inc

Ascendis Health Ltd

Baxter International Inc

AstraZeneca Plc

Adcock Ingram Holdings Ltd

Merck & Co Inc

Pfizer Inc

Adcock Ingram Holdings Ltd

Baxter International Inc

Merck & Co Inc

Ascendis Health Ltd

AstraZeneca Plc

Novartis AG

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Aspen Pharmacare Holdings Ltd - Key Facts

Aspen Pharmacare Holdings Ltd - Key Employees

Aspen Pharmacare Holdings Ltd - Key Employee Biographies

Aspen Pharmacare Holdings Ltd - Major Products and Services

Aspen Pharmacare Holdings Ltd - History

Aspen Pharmacare Holdings Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

Aspen Pharmacare Holdings Ltd - Business Description

Business Segment: Commercial Pharmaceuticals

Overview

Performance

Business Segment: Manufacturing

Overview

Performance

Geographical Segment: Africa Middle East

Performance

Geographical Segment: Americas

Performance

Geographical Segment: Asia

Performance

Geographical Segment: Australasia

Performance

Geographical Segment: Europe CIS

Performance

Aspen Pharmacare Holdings Ltd - Corporate Strategy

Aspen Pharmacare Holdings Ltd - SWOT Analysis

SWOT Analysis - Overview

Aspen Pharmacare Holdings Ltd - Strengths

Aspen Pharmacare Holdings Ltd - Weaknesses

Aspen Pharmacare Holdings Ltd - Opportunities

Aspen Pharmacare Holdings Ltd - Threats

Aspen Pharmacare Holdings Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Aspen Pharmacare Holdings Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Aug 31, 2023: Aspen Revenue Exceeds R40 Billion with Accelerated Medium-Term Growth Anticipated

Mar 02, 2023: Aspen Pharmacare announces interim financial results for the six months ended 31 December 2022

Feb 12, 2023: Aspen delivers double digit organic growth in normalised EBITDA, operating profit and earnings

Feb 12, 2023: Aspen Pharmacare Holdings Announces Annual Financial Statements for the year ended 30 June 2022

Dec 12, 2022: Aspen, CEPI and the Bill & Melinda Gates Foundation expand commitments to improve access to vaccines in Africa

Aug 31, 2022: Aspen delivers double digit organic revenue grown in normalised EBITDA, Operating Profit and Earnings

Aug 31, 2022: Aspen delivers double digit organic growth in normalised ebitda, operating profit and earnings

Aug 31, 2022: Aspen concludes a collaboration agreement to manufacture and make available four Aspen-branded vaccines for Africa

Mar 24, 2022: Aspen announces R500 million investment at 4th SAIC

Mar 09, 2022: Aspen delivers double digit organic revenue grown in constant exchange rates

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Aspen Pharmacare Holdings Ltd, Key Facts

Aspen Pharmacare Holdings Ltd, Key Employees

Aspen Pharmacare Holdings Ltd, Key Employee Biographies

Aspen Pharmacare Holdings Ltd, Major Products and Services

Aspen Pharmacare Holdings Ltd, History

Aspen Pharmacare Holdings Ltd, Other Locations

Aspen Pharmacare Holdings Ltd, Subsidiaries

Aspen Pharmacare Holdings Ltd, Joint Venture

Aspen Pharmacare Holdings Ltd, Key Competitors

Aspen Pharmacare Holdings Ltd, Ratios based on current share price

Aspen Pharmacare Holdings Ltd, Annual Ratios

Aspen Pharmacare Holdings Ltd, Annual Ratios (Cont…1)

Aspen Pharmacare Holdings Ltd, Annual Ratios (Cont…2)

Aspen Pharmacare Holdings Ltd, Interim Ratios

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Aspen Pharmacare Holdings Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Aspen Pharmacare Holdings Ltd, Performance Chart (2019 – 2023)

Aspen Pharmacare Holdings Ltd, Ratio Charts

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Aspen Pharmacare Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports